Further gain- or loss-of-function assays revealed that lnc-ZEB2-19, as a tumor suppressor gene, significantly inhibited metastasis, stemness, and resistance to lenvatinib of HCC cells. Here, ZEB2 is linked to hepatocellular carcinoma.